Active ingredient
Romosozumab
3 finished FDA listings contain Romosozumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ROMOSOZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 105 mg/1.17ml
- Brand names in FDA listings
- Evenity
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2123126
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761062 | AMGEN INC | 2019-04-09 | 3 |
Official labeling on DailyMed
- EVENITY (ROMOSOZUMAB-AQQG) INJECTION, SOLUTION [AMGEN, INC] · version 21 · 2026-08-03
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.